What Are Peptides?

A peptide is a molecule composed of two or more amino acids linked by peptide bonds. Proteins are essentially long peptide chains. Short peptides — typically fewer than 50 amino acids — often function as signaling molecules, binding to receptors and triggering specific biological responses.

The body produces thousands of endogenous peptides that regulate virtually every physiological process: hormones like insulin and glucagon are peptides, as are many neurotransmitters, growth factors, and immune modulators.

Research peptides are synthetic or bioidentical compounds designed to mimic or modulate these natural signaling pathways. They are studied in academic and clinical settings for applications in tissue repair, inflammation, aging, and neurological function. The regulatory status of research peptides varies significantly by country, and the clinical evidence base ranges from robust (for some) to preliminary (for others).

• Peptides are distinct from small-molecule drugs — they are larger, more specific, and typically degraded rapidly by the body
• Most research peptides are administered subcutaneously or intranasally due to poor oral bioavailability
• The field is evolving rapidly — many peptides have promising preclinical data but limited large-scale human trials
• Quality, purity, and sourcing are significant variables in research settings — this page does not address sourcing

Recovery & Repair — BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. It has been studied extensively in animal models for its effects on tissue healing, including tendon, ligament, muscle, and gastrointestinal repair.

Preclinical research suggests BPC-157 promotes angiogenesis (new blood vessel formation), modulates nitric oxide pathways, and may accelerate the healing of musculoskeletal injuries. It has also been studied for its potential gastroprotective effects and influence on the gut-brain axis.

Human clinical data remains limited. Most evidence comes from rodent studies, which show consistent and reproducible healing effects. BPC-157 is discussed extensively in sports medicine and biohacking communities, though it is not approved by the FDA for therapeutic use.

• Derived from a naturally occurring gastric protein — not a foreign compound
• Studied for tendon, ligament, muscle, and GI tissue repair in animal models
• Modulates nitric oxide signaling and promotes angiogenesis
• No approved human clinical trials as of this writing — evidence is primarily preclinical

Recovery & Repair — TB-500

TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide found in high concentrations in platelets and wound fluid. Thymosin Beta-4 plays a central role in actin regulation — a protein essential for cell migration, tissue repair, and wound healing.

Research suggests TB-500 promotes the migration of endothelial cells and keratinocytes to wound sites, reduces inflammation, and supports the regeneration of blood vessels and cardiac tissue. It has been studied in the context of cardiac repair following myocardial infarction, as well as musculoskeletal recovery.

Like BPC-157, TB-500 is widely discussed in athletic recovery contexts. The two are often combined in what is referred to as a "recovery stack." Clinical evidence in humans is limited, and it is not approved for therapeutic use.

• Synthetic analog of Thymosin Beta-4 — a naturally occurring wound-healing peptide
• Regulates actin polymerization, which governs cell migration and tissue repair
• Studied for cardiac, musculoskeletal, and wound healing applications
• Frequently paired with BPC-157 in recovery-focused research stacks

Longevity & Cellular Health — MOTS-c

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondria-derived peptide encoded within mitochondrial DNA — a discovery that challenged the long-held assumption that mitochondria do not produce functional peptides.

Research suggests MOTS-c acts as a metabolic regulator, improving insulin sensitivity, activating AMPK (a key energy-sensing enzyme), and enhancing mitochondrial function. Animal studies have shown that MOTS-c administration can reverse age-related metabolic decline and improve physical performance in older mice.

MOTS-c levels decline with age, and this decline is associated with reduced metabolic flexibility and increased insulin resistance. It represents a novel class of mitochondria-derived peptides — called mitokines — that communicate metabolic status to the rest of the body.

• Encoded within mitochondrial DNA — a recently discovered class of mitochondria-derived peptide
• Activates AMPK and improves insulin sensitivity in preclinical models
• Levels decline with age — associated with metabolic decline
• Studied for applications in metabolic health, physical performance, and longevity

Longevity & Cellular Health — Humanin

Humanin is another mitochondria-derived peptide (mitokine) encoded within the 16S rRNA region of mitochondrial DNA. It was originally identified for its neuroprotective properties — specifically its ability to protect neurons from amyloid-beta toxicity, a hallmark of Alzheimer's disease.

Subsequent research has expanded the understanding of Humanin's role to include cytoprotection (protecting cells from stress-induced death), anti-inflammatory signaling, and metabolic regulation. Humanin levels decline with age and are lower in individuals with age-related diseases.

Humanin signals through receptors on the cell surface and can cross the blood-brain barrier, giving it potential relevance in both peripheral and central nervous system health. It is considered one of the most promising mitokines in longevity research.

• Mitochondria-derived peptide with neuroprotective and cytoprotective properties
• Protects neurons from amyloid-beta toxicity in preclinical models
• Levels decline with age and in age-related disease states
• Crosses the blood-brain barrier — relevant to both systemic and neurological health

Longevity & Cellular Health — Epitalon

Epitalon (also spelled Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from Epithalamin, a natural polypeptide produced by the pineal gland. It was developed by Russian researcher Vladimir Khavinson and has been studied for several decades, primarily in Russian and Eastern European research institutions.

Epitalon is most notable for its proposed effects on telomere length. Research — primarily from Khavinson's group — suggests Epitalon activates telomerase, the enzyme responsible for maintaining and extending telomeres. Telomere shortening is a hallmark of cellular aging, and telomerase activation is a subject of significant longevity research.

Additional research suggests Epitalon regulates melatonin production, modulates the hypothalamic-pituitary axis, and has antioxidant properties. The evidence base, while substantial in volume, is largely from Russian institutions and animal models, with limited independent replication in Western research settings.

• Synthetic tetrapeptide derived from the pineal gland peptide Epithalamin
• Proposed to activate telomerase and support telomere maintenance
• Studied for effects on melatonin regulation, antioxidant activity, and longevity
• Most research originates from Russian institutions — independent replication is limited

Skin & Hair — GHK-Cu

GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper complex) is a naturally occurring copper peptide found in human plasma, saliva, and urine. It was first identified in the 1970s and has since been studied extensively for its roles in wound healing, skin regeneration, and anti-aging.

GHK-Cu stimulates collagen and elastin synthesis, promotes angiogenesis, and activates genes associated with tissue remodeling. It also has antioxidant and anti-inflammatory properties. Topical GHK-Cu is widely used in cosmetic formulations for its skin-tightening and regenerative effects.

Beyond topical applications, systemic GHK-Cu has been studied for its effects on gene expression — research by Loren Pickart and colleagues suggests it resets the expression of a large number of human genes toward a younger, healthier state. It is also discussed in the context of hair follicle stimulation and hair loss.

• Naturally occurring copper peptide — found in human plasma and wound fluid
• Stimulates collagen, elastin, and glycosaminoglycan synthesis
• Topical use is well-established in cosmetic dermatology
• Systemic research suggests broad gene expression effects relevant to aging
• Studied for hair follicle stimulation and androgenic alopecia

Cognitive Research — Semax

Semax is a synthetic heptapeptide analog of ACTH (adrenocorticotropic hormone) developed in Russia in the 1980s. It is approved as a pharmaceutical drug in Russia and Ukraine for the treatment of stroke, cognitive impairment, and peptic ulcers, though it is not approved in the United States or European Union.

Semax is studied for its nootropic and neuroprotective properties. Research suggests it increases BDNF (brain-derived neurotrophic factor) levels, modulates dopaminergic and serotonergic systems, and has anti-inflammatory effects in the central nervous system. It is typically administered intranasally.

Users and researchers report effects on focus, memory, and stress resilience. The evidence base includes both animal studies and limited human clinical trials, primarily from Russian institutions. It is considered one of the better-studied peptides in the cognitive enhancement space.

• Synthetic ACTH analog — approved as a pharmaceutical in Russia and Ukraine
• Increases BDNF, supporting neuroplasticity and neuroprotection
• Modulates dopaminergic and serotonergic neurotransmission
• Administered intranasally — not approved by FDA or EMA
• Studied for cognitive enhancement, neuroprotection, and stress resilience

Cognitive Research — Selank

Selank is a synthetic heptapeptide analog of the endogenous immunomodulatory peptide tuftsin. Like Semax, it was developed in Russia and is approved as a pharmaceutical there for the treatment of anxiety and cognitive disorders.

Selank is primarily studied for its anxiolytic (anti-anxiety) and nootropic effects. Research suggests it modulates GABA receptor activity, increases BDNF expression, and has immunomodulatory properties. Unlike benzodiazepines, it does not appear to cause sedation or dependence in animal models.

Selank is often discussed alongside Semax — the two are sometimes combined for complementary cognitive effects. It is typically administered intranasally and has a favorable safety profile in the available research, though large-scale independent clinical trials are lacking.

• Synthetic tuftsin analog — approved as a pharmaceutical in Russia
• Anxiolytic effects without sedation or dependence in preclinical models
• Modulates GABA receptor activity and increases BDNF
• Immunomodulatory properties — studied for immune regulation alongside cognitive effects
• Often paired with Semax for complementary cognitive and stress-resilience applications

Popular Research Stacks

In research and biohacking communities, peptides are frequently combined into "stacks" — combinations chosen for complementary mechanisms. The following are the most commonly discussed combinations. These are presented for educational purposes only. No protocols, dosing, or sourcing information is provided on this site.

• Recovery Stack — BPC-157 + TB-500: Combined for synergistic tissue repair. BPC-157 targets local healing and angiogenesis; TB-500 supports systemic cell migration and inflammation modulation.
• Glow Stack — GHK-Cu + MOTS-c + Epitalon: Focused on skin quality, cellular aging, and telomere maintenance. GHK-Cu addresses collagen and skin regeneration; MOTS-c supports metabolic and mitochondrial health; Epitalon targets telomerase activation.
• Longevity Stack — GHK-Cu + MOTS-c + Humanin + Epitalon: A broader cellular aging stack combining tissue regeneration (GHK-Cu), mitochondrial signaling (MOTS-c + Humanin), and telomere biology (Epitalon).
• Cognitive Stack — Semax + Selank: Complementary nootropic and anxiolytic effects. Semax for focus and BDNF upregulation; Selank for anxiety reduction and immune modulation.

Important Considerations

The peptide research space is characterized by significant promise and significant uncertainty. Many of the most discussed peptides have robust preclinical evidence but limited large-scale human clinical trials. The regulatory landscape varies widely by country — peptides that are approved pharmaceuticals in one jurisdiction may be unregulated research chemicals in another.

Quality and purity are critical variables. Research peptides are not subject to the same manufacturing standards as pharmaceutical drugs in most countries, and contamination, incorrect concentration, and misidentification are documented risks in the unregulated market.

This page is intended solely for educational purposes. Nothing here constitutes medical advice, and no protocols, dosing, or sourcing guidance is provided. Anyone considering peptide use should consult a qualified healthcare provider familiar with the current evidence base.